Published in Cardiovascular Week, January 30th, 2006
According to a study from Germany, "Improved prognosis of patients with chronic systolic heart failure by treatment with beta-blockers has been shown in several randomized controlled multicenter trials. However, in clinical practice only a part of heart failure patients meet the inclusion criteria of these trials."
A. Jost and colleagues at Herzzentrum Ludwigshafen wrote, "The present study evaluates whether reduction of mortality by beta-blockers also can be achieved in patients presenting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Week